Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Compliance with Global Animal Testing Regulations

Posted on By

SOP for Compliance with Global Animal Testing Regulations

Standard Operating Procedure (SOP) for Compliance with Global Animal Testing Regulations

1) Purpose

The purpose of this Standard Operating Procedure (SOP) is to ensure that all animal testing conducted during preclinical studies complies with global animal testing regulations. This SOP outlines the procedures for adhering to international guidelines such as the OECD Principles of Good Laboratory Practice (GLP), the U.S. FDA regulations, and the European Union regulations for animal welfare and testing. Compliance with these regulations is crucial to ensure ethical standards, data integrity, and acceptance by regulatory authorities.

2) Scope

This SOP applies to all personnel involved in the planning, conduct, and oversight of animal testing in preclinical studies. It includes the adherence to global standards, documentation practices, ethical considerations, and reporting requirements for animal testing. This SOP is relevant to study directors, animal facility managers, regulatory affairs personnel, and all stakeholders involved in animal studies.

3) Responsibilities

  • Study Directors: Oversee compliance with global animal testing regulations, ensure ethical considerations are met, and ensure that all protocols are designed and executed according to relevant guidelines.
  • Animal Facility Managers: Ensure that the animal testing facility is maintained in compliance with regulatory standards and that animals are handled humanely according to applicable animal welfare guidelines.
  • Regulatory Affairs Personnel: Ensure that animal testing complies with international regulatory requirements and that documentation and reports are prepared for submission to regulatory authorities.
  • Quality Assurance (QA): Audit animal testing procedures, monitor compliance with regulations, and ensure that appropriate records are kept for regulatory inspections and audits.
  • Veterinary Staff: Ensure the health and well-being of the animals used in the study and provide veterinary care when necessary. Monitor animal welfare throughout the study.
See also  SOP for Preclinical Study Data Review Meetings

4) Procedure

The following steps outline the procedure for ensuring compliance with global animal testing regulations:

  1. Step 1: Review of Applicable Regulations
    1. Ensure that the study is compliant with relevant global animal testing regulations, including the OECD Principles of GLP, U.S. FDA regulations, and European Union animal welfare guidelines.
    2. Review country-specific regulations for animal welfare and testing, ensuring that all legal and ethical requirements are considered in the study design and implementation.
    3. Ensure that the animal testing protocol includes provisions for the humane treatment of animals, minimization of suffering, and the use of alternatives to animal testing where possible.
  2. Step 2: Animal Ethics Committee Review
    1. Submit the animal testing protocol for review and approval by the relevant ethics or animal welfare committee before initiating any studies involving animals.
    2. Ensure that the ethics committee evaluates the study’s scientific validity, ethical considerations, and adherence to legal requirements.
    3. Ensure that any modifications to the protocol, such as changes to animal handling or study procedures, are reviewed and approved by the ethics committee.
  3. Step 3: Animal Welfare and Handling
    1. Ensure that animals are housed in appropriate environments that meet the regulatory requirements for housing, nutrition, and care.
    2. Ensure that animals are handled humanely and are provided with necessary veterinary care as required by regulations and the study protocol.
    3. Ensure that any pain or distress is minimized, and that anesthesia, analgesia, or euthanasia methods are in place as required by the study protocol and ethical guidelines.
  4. Step 4: Training of Personnel
    1. Ensure that all personnel involved in animal testing are trained and competent in handling animals in compliance with ethical and regulatory standards.
    2. Ensure that personnel are trained in the proper use of equipment, sample collection techniques, and emergency response protocols.
    3. Provide ongoing training to ensure that staff remain updated on changes to animal welfare regulations and best practices for animal handling.
  5. Step 5: Documentation and Record Keeping
    1. Maintain accurate records of animal usage, including the species, number of animals, health status, and study procedures conducted.
    2. Document all approvals from the animal ethics committee, as well as any deviations from the study protocol, including rationale for the changes.
    3. Ensure that records are maintained in accordance with GLP and regulatory requirements, and that they are available for audits or inspections by regulatory authorities.
  6. Step 6: Monitoring and Auditing
    1. Conduct regular internal audits to ensure compliance with animal testing regulations and the study protocol. Address any issues or deviations promptly.
    2. Ensure that animal welfare is regularly monitored by trained personnel, and that any signs of distress, illness, or injury are addressed immediately.
    3. Ensure that the study director and QA personnel are notified of any non-compliance issues or ethical concerns during the study.
  7. Step 7: Reporting and Submission
    1. Prepare detailed reports of the animal study, including all relevant data, methodologies, and any deviations from the protocol. Ensure that the reports comply with regulatory requirements for submission to authorities.
    2. Submit the report to the relevant regulatory bodies and ensure that it meets the guidelines for animal testing studies in the jurisdiction where the study was conducted.
    3. Ensure that the final report includes a summary of the ethical considerations, animal welfare actions taken, and any corrective measures implemented during the study.
  8. Step 8: Archiving and Disposal
    1. Ensure that all study-related records, including animal health and treatment logs, protocol documents, and final reports, are archived according to internal policies and regulatory requirements.
    2. Ensure that all unused biological samples and materials are disposed of following biosafety and waste disposal regulations.
    3. Ensure that records are retained for the required duration and can be accessed for future reference, audits, or regulatory reviews.
See also  SOP for Preclinical Safety Pharmacology Studies

5) Documents

The following documents should be maintained to ensure compliance with global animal testing regulations:

  1. Study Protocols
  2. Animal Ethics Committee Approvals
  3. Animal Welfare and Health Records
  4. Training Records
  5. Audit and Monitoring Records
  6. Final Study Reports
  7. Regulatory Submission Documents

6) Abbreviations

  • GLP: Good Laboratory Practices
  • FDA: Food and Drug Administration
  • QA: Quality Assurance
  • OECD: Organisation for Economic Co-operation and Development
  • IND: Investigational New Drug

7) References

References to regulatory guidelines and scientific literature that support this SOP:

  • OECD Guidelines for Good Laboratory Practice (GLP)
  • FDA Regulations for Animal Testing and Welfare
  • European Union Animal Testing Regulations
  • International Standards for Ethical Animal Testing
See also  SOP for Screening Formulations for Injectable Delivery

8) Version

Version 1.0: Initial version of the SOP.

9) Annexure

Animal Study Compliance Checklist

Study ID Compliance Area Compliance Status Notes
Animal Welfare
Regulatory Documentation
Ethics Committee Approval
Drug Discovery Tags:Drug Discovery SOP, SOP for ADMET Testing, SOP for Bioanalytical Methods, SOP for Biomarker Discovery, SOP for Clinical Data Management, SOP for Clinical Trial Protocols, SOP for Drug Delivery Systems, SOP for Drug Formulation, SOP for Drug Metabolism, SOP for Good Laboratory Practices (GLP), SOP for Good Manufacturing Practices (GMP), SOP for High-Throughput Screening, SOP for In Silico Modeling, SOP for In Vitro Assays, SOP for In Vivo Models, SOP for Lead Optimization, SOP for Medicinal Chemistry, SOP for Pharmacodynamics, SOP for Pharmacokinetics, SOP for Preclinical Safety Testing, SOP for Preclinical Studies, SOP for Protein Binding Studies, SOP for Regulatory Compliance in Drug Discovery, SOP for Target Identification, SOP for Toxicology Studies

Post navigation

Previous Post: Tablets: SOP for Vacuum Transfer Systems in Powder Handling – V 2.0
Next Post: Ointments: SOP for Preventing Contamination at Each Stage – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

English
 - 
en
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version